50432-01-4

Basic information

• Product Name: 4-AMINO-2,6-DIPHENYLPHENOL
• Synonyms: 5'-AMINO-2'-HYDROXY-M-TERPHENYL;4-AMINO-2,6-DIPHENYLPHENOL;Aminodiphenylphenol
• CAS NO: 50432-01-4
• Molecular Formula: C₁₈H₁₅NO
• Molecular Weight: 261.32
• Product Categories: Aromatic Phenols;Organic Building Blocks;Oxygen Compounds;Phenols
• Mol File: 50432-01-4.mol
• Article Data: 6

Chemical Properties

• Melting Point: 148-150 °C(lit.)
• Boiling Point: 463.5oC at 760 mmHg
• Flash Point: 234.1oC
• Appearance: /
• Density: 1.183g/cm3
• Vapor Pressure: 3.27E-09mmHg at 25°C
• Refractive Index: 1.66
• PKA: 10.29±0.23(Predicted)
• Stability: Stable. Incompatible with strong oxidizing agents.
• CAS DataBase Reference: 4-AMINO-2,6-DIPHENYLPHENOL(CAS DataBase Reference)
• NIST Chemistry Reference: 4-AMINO-2,6-DIPHENYLPHENOL(50432-01-4)
• EPA Substance Registry System: 4-AMINO-2,6-DIPHENYLPHENOL(50432-01-4)

Safety Data

• Hazard Codes: Xi
• Statements: 36/37/38
• Safety Statements: 26-37/39
• WGK Germany: 3
• Hazardous Substances Data: 50432-01-4(Hazardous Substances Data)

Usage

Description

4-Amino-2,6-diphenylphenol is an organic compound characterized by the presence of an amino group attached to a phenol moiety, with two phenyl rings at the 2nd and 6th positions. This molecule is known for its reactivity and potential applications in various chemical processes.

Uses

Used in Chemical Synthesis:
4-Amino-2,6-diphenylphenol is used as a precursor in the synthesis of various organic compounds. Specifically, it undergoes diazotization in glacial acetic acid to form 4-diazo-2,6-diphenylcyclohexa-2,5-dienone, which can be further utilized in the preparation of other complex organic molecules.
While the provided materials do not specify other industries or applications, it is worth noting that 4-Amino-2,6-diphenylphenol could potentially be used in pharmaceutical, agrochemical, or material science industries, given its chemical properties and reactivity. Further research and development would be required to explore and validate these potential uses.

InChI:InChI=1/C18H15NO/c19-15-11-16(13-7-3-1-4-8-13)18(20)17(12-15)14-9-5-2-6-10-14/h1-12,20H,19H2

Upstream product

• 2423-73-6 2,6-diphenyl-4-nitrophenol 
• 2432-11-3 (1,1';3',1''-terphenyl)-2'-ol 

Downstream Products

• 2432-11-3 (1,1';3',1''-terphenyl)-2'-ol 
• 10081-39-7 betaine 30 
• 115141-64-5 4-(4-Cyanphenyl)-1-(4-hydroxy-3,5-diphenylphenyl)-2,6-diphenylpyridinium-tetrafluoroborat 
• 190844-70-3 N-(o-bromobenzylidene)-4-amino-2,6-diphenylphenol 
• 666718-41-8 N-(2,6-di-phenyl-1-hydroxyphenyl)-3,5-di-t-butylsalicylaldimine 
• 666718-40-7 N-(2,6-di-phenyl-1-hydroxyphenyl)-salycilaldimine 
• 115141-66-7 4-(4-Carboxyphenyl)-1-(4-hydroxy-3,5-diphenylphenyl)-2,6-diphenylpyridinium-tetrafluoroborat 
• 1037222-98-2 C₂₆H₂₁NO₃ 
• 1037222-94-8 C₂₆H₂₁NO₂ 
• 1037222-99-3 C₂₆H₂₁NO₃ 
• 1037223-01-0 C₂₉H₂₇NO₂ 
• 1037222-95-9 C₂₆H₂₁NO₂ 
• 1037222-96-0 C₂₆H₂₁NO₃ 
• 1037223-02-1 C₂₉H₂₁NO₂ 

Relevant articles and documents

How many molecular layers of polar solvent molecules control chemistry? the concept of compensating dipoles

The extension of the solvent influence of the shell into the volume of a polar medium was examined by means of anti-collinear dipoles on the basis of the ET(30) solvent polarity scale (i.e., the molar energy of excitation of a pyridinium-N-phen

Nitro-substituted 4-[(phenylmethylene)imino]phenolates: Solvatochromism and their use as solvatochromic switches and as probes for the investigation of preferential solvation in solvent mixtures

Four 4-[[(4-nitrophenyl)methylene]imino]phenols (2aa-d) were synthesized. After deprotonation in solution, they formed the solvatochromic phenolates 3aa-d, which revealed a reversal in solvatochromism. Their UVa-vis spectroscopic behavior was explained on

Design, synthesis and biological testing of a novel series of anti-inflammatory drugs

Many of the non-steroidal anti-inflammatory drugs (NSAIDs) currently marketed produce severe gastro-toxic side effects. The benefits of producing NSAIDs without these side effects are obvious, particularly for patients requiring long-term therapy. The aim of this investigation was to produce novel NSAIDs, based on paracetamol, that exhibit little or no gastro-toxicity. The work covers design, synthesis and testing of 13 drug candidates. The analgesic and anti-inflammatory potencies of the drug candidates were measured using the mouse abdominal constriction assay and the carrageenan-induced rat paw oedema assay, respectively. The stomachs of the rats were examined post-mortem, to assess the gastro-toxicity of the drugs. Of the 13 compounds described herein, 11 were shown to possess analgesic activity at 2-10 times the potency of aspirin, while 8 demonstrated anti-inflammatory activity at 3-10 times the potency of aspirin. Significantly, all of the compounds showed very low gastro-toxicity when compared with aspirin. The results of this study indicate that it is possible to develop novel, potent NSAIDs based on the structure of paracetamol. These compounds have the advantage of demonstrating much lower gastro-toxicity than NSAIDs currently available. Drugs of this type may, in future, provide effective treatments for inflammatory disorders.